32828 Federal Register / Vol. 61, No. 123 / Tuesday, June 25, 1996 / Notices

Estimated Total Annual Burden

Hours: 500.

Additional Information: Copies of the

proposed collection may be obtained by

writing to The Administration for

Children and Families, Office of

Information Services, Division of

Information Resource Management

Services, 370 L’Enfant Promenade, S.W.,

Washington, D.C. 20447, Attn: ACF

Reports Clearance Officer.

OMB Comment: OMB is required to

make a decision concerning the

collection of information between 30

and 60 days after publication of this

document in the Federal Register.

Therefore, a comment is best assured of

having its full effect if OMB receives it

within 30 days of publication. Written

comments and recommendations for the

proposed information collection should

be sent directly to the following: Office

of Management and Budget, Paperwork

Reduction Project, 725 17th Street,

N.W., Washington, D.C. 20503, Attn:

Ms. Wendy Taylor.

Dated June 19, 1996.

Larry Guerrero,

Director, Office of Information Management

Services.

[FR Doc. 96–16050 Filed 6–24–96; 8:45 am]

BILLING CODE 4184–01–M

Submission of OMB Review; Comment

Request

Title: Objective Work Plan, ANA

Program Narrative, Application for

Federal Assistance.

OMB No.: 0980–0204.

Description: The information

collected by Program Narrative;

Application for Federal Assistance, the

Objective Work Plan, is needed to

properly administer and monitor the

Administration for Native Americans’

(ANA) Program’s competitive areas—

Social and Economic Development

Strategies (SEDS), ANA Reservation and

Enhancement, and ANA Mitigation of

Environmental Impacts to Indian Lands

Due to Department of Defense Activities

by providing information in an

application for a grant award. This data

is used by legislative-mandated Native

American review panels, and ANA, as

the basis for recommendations for the

decisions to award competitive ANA

grants.

Respondents: State, Local or Tribal

Govt.

ANNUAL BURDEN ESTIMATES

Instrument

Number of

respondents

Number

of responses

per respondent

Average

burden

hours

per response

Total

burden

hours

OWP ................................................................................................................................................................ 571 1 29.5 17,800

Estimated Total Annual Burden

Hours: 17,800.

Additional Information: Copies of the

proposed collection may be obtained by

writing to the Administration or

Children and Families, Office of

Information Services, Division of

Information Resource Management

Services, 370 L’Enfant Promenade, S.W.,

Washington, D.C. 20447, Attn: ACF

Reports Clearance Officer.

OMB Comment: OMB is required to

make a decision concerning the

collection of information between 30

and 60 days after publication of this

document in the Federal Register.

Therefore, a comment is best assured of

having its full effect if OMB receives it

within 30 days of publication. Written

comments and recommendations for the

proposed information collection should

be sent directly to the following: Office

of Management and Budget, Paperwork

Reduction Project, 725 17th Street,

N.W., Washington, D.C. 20503, Attn:

Ms. Wendy Taylor.

Dated: June 19, 1996.

Larry Guerrero,

Director, Office of Information Management

Services.

[FR Doc. 96–16051 Filed 6–24–96; 8:45 am]

BILLING CODE 4184–01–M

Submission for OMB Review;

Comment Request

Title: Objective Progress Report

(OPR), Administration for Native

Americans.

OMB No.: 0980–0155.

Description: The information

collected by the Objective Progress

Report on an ANA grantee’s project

progress is needed to properly

administer and monitor the progress of

Administration for Native American’

competitive areas grants—Social and

Economic Development Strategies

(SEDS), ANA Environmental

Enhancement, and ANA Mitigation of

Environment Impacts to Indian Lands

due to Department of Defense Activities.

This information is used to perform

legislatively required Federal financial

and program management oversight

functions.

Respondents: State, Local and Tribal

Govt.

ANNUAL BURDEN ESTIMATES

Instrument

Number of

respondents

Number

of responses

per respondent

Average

burden

hours

per response

Total

burden

hours

OPR 250 2 2 1,000

Estimated Total Annual Burden

Hours: 1,000.

Additional Information: Copies of the

proposed collection may be obtained by

writing to The Administration for

Children and Families, Office of

Information Services, Division of

Information Resource Management

Services, 370 L’Enfant Promenade, SW.,

Washington, D.C. 20447, Attn: ACF

Reports Clearance Officer.
Federal Register / Vol. 61, No. 123 / Tuesday, June 25, 1996 / Notices 32829

OMB Comment: OMB is required to

make a decision concerning the

collection of information between 30

and 60 days after publication of this

document in the Federal Register.

Therefore, a comment is best assured of

having its full effect if OMB receives it

within 30 days of publication. Written

comments and recommendations for the

proposed information collection should

be sent directly to the following: Office

of Management and Budget, Paperwork

Reduction Project, 725 17th Street,

N.W., Washington, D.C. 20503, Attn:

Ms. Wendy Taylor.

Dated: June 19, 1996.

Larry Guerrero,

Director, Office of Information Management

Services.

[FR Doc. 96–16070 Filed 6–24–96; 8:45 am]

BILLING CODE 4184–01–M

Food and Drug Administration

Advisory Committees; Notice of

Meetings

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: This notice announces

forthcoming meetings of public advisory

committees of the Food and Drug

Administration (FDA). This notice also

summarizes the procedures for the

meetings and methods by which

interested persons may participate in

open public hearings before FDA’s

advisory committees.

FDA has established an Advisory

Committee Information Hotline (the

hotline) using a voice-mail telephone

system. The hotline provides the public

with access to the most current

information on FDA advisory committee

meetings. The advisory committee

hotline, which will disseminate current

information and information updates,

can be accessed by dialing 1–800–741–

8138 or 301–443–0572. Each advisory

committee is assigned a 5-digit number.

This 5-digit number will appear in each

individual notice of meeting. The

hotline will enable the public to obtain

information about a particular advisory

committee by using the committee’s 5-

digit number. Information in the hotline

is preliminary and may change before a

meeting is actually held. The hotline

will be updated when such changes are

made.

MEETINGS: The following advisory

committee meetings are announced:

Vaccines and Related Biological

Products Advisory Committee

Date, time, and place. July 10 and 11,

l996, 8 a.m., Holiday Inn—Bethesda,

Versailles Ballrooms I and II, 8120

Wisconsin Ave., Bethesda, MD.

Type of meeting and contact person.

Closed committee deliberations, July 10,

l996, 8 a.m. to 10 a.m., open committee

discussion, 10 a.m. to 3:45 p.m.; open

public hearing, 3:45 p.m. to 4:30 p.m.,

unless public participation does not last

that long; closed committee

deliberations, July 11, 1996, 8 a.m. to

8:45 a.m.; open committee discussion,

8:45 a.m. to 12 m.; open public hearing,

12 m. to 12:30 p.m., unless public

participation does not last that long;

open committee discussion, 12:30 p.m.

to 2 p.m.; closed committee

deliberations, 2 p.m. to 3:30 p.m.; Nancy

T. Cherry or Sandy M. Salins, Center for

Biologics Evaluation and Research

(HFM–21), Food and Drug

Administration, 1401 Rockville Pike,

Rockville, MD 20852, 301–827–0314, or

FDA Advisory Committee Information

Hotline, 1–800–741–8138 (301–443–

0572 in the Washington, DC area),

Vaccines and Related Biological

Products Advisory Committee, code

12388. Please call the hotline for

information concerning any possible

changes.

General function of the committee.

The committee reviews and evaluates

data on the safety and effectiveness of

vaccines intended for use in the

diagnosis, prevention, or treatment of

human diseases.

Agenda—Open public hearing.

Interested persons may present data,

information, or views, orally or in

writing, on issues pending before the

committee. Those desiring to make

formal presentations should notify the

contact person before July 3, 1996, and

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

required to make their comments.

Open committee discussion. On July

10, 1996, the committee will review

safety and efficacy data pertaining to a

diphtheria/tetanus/acellular pertussis

vaccine manufactured by SmithKline

Beecham. On July 11, 1996, the

committee will review safety and

comparative immunogenicity data

pertaining to a liquid version of an

Haemophilus b conjugate vaccine

manufactured by Merck & Co. The

committee will also hear a briefing on

proposed changes in the polio vaccine

recommendations, and a briefing on a

research program in the Division of

Viral Products.

Closed committee deliberations. On

July 10 and 11, l996, the committee will

review trade secret and/or confidential

commercial information relevant to

pending product licensing applications

or amendments. These portions of the

meeting will be closed to permit

discussion of this information (5 U.S.C.

552b(c)(4)). On July 11, l996, the

committee will also review data of a

personal nature where disclosure would

constitute a clearly unwarranted

invasion of personal privacy. This

portion of the meeting will be closed to

permit discussion of this information (5

U.S.C. 552b(c)(6)).

Circulatory System Devices Panel of

the Medical Devices Advisory

Committee

Date, time, and place. July 15, 1996,

7:30 a.m., Corporate Bldg., conference

room 020B, 9200 Corporate Blvd.,

Rockville, MD. A limited number of

overnight accommodations have been

reserved at the Courtyard by Marriott,

2500 Research Blvd., Rockville, MD.

Attendees requiring overnight

accommodations may contact the hotel

at 301–670–6700, and reference the FDA

Panel meeting block. Reservations will

be confirmed at the group rate based on

availability. Attendees with a disability

requiring special accommodations

should contact Shirley Meeks,

Conference Management, 301–594–

1283, ext. 113. The availability of

appropriate accommodations cannot be

assured unless prior notification is

received.

Type of meeting and contact person.

Closed committee deliberations, 7:30

a.m. to 8:30 a.m.; open public hearing,

8:30 a.m. to 9:30 a.m., unless public

participation does not last that long;

open committee discussion, 9:30 a.m. to

3:30 p.m.; Ramiah Subramanian, Center

for Devices and Radiological Health

(HFZ–450), Food and Drug

Administration, 9200 Corporate Blvd.,

Rockville, MD 20850, 301–443–8320, or

FDA Advisory Committee Information

Hotline, 1–800–741–8138 (301–443–

0572 in the Washington, DC area),

Circulatory System Devices Panel, code

12625. Please call the hotline for

information concerning any possible

changes.

General function of the committee.

The committee reviews and evaluates

data on the safety and effectiveness of

marketed and investigational devices

and makes recommendations for their

regulation.

Agenda—Open public hearing.

Interested persons may present data,